Puho Pharmaceutical Co.,Limited

Cisatracurium besilate

• Category :

  Intermediates/Pharmaceutical intermediates

• Synonyms :

  Cisatracurium besylate;(1R,1'R,2R,2'R)-2,2'-[1,5-Pentanediylbis[oxy(3-oxo-3,1-propanediyl)]]bis[1-[(3,4-dimethoxyphenyl)methyl]-1,2,3,4-tetrahydro-6,7-dimethoxy-2-methyl-isoquinolinium dibenzenesulfonate;(1R,2R,1'R,2'R)-2,2'-{pentane-1,5-diylbis[oxy(3-oxopropane-3,1-diyl)]}bis[1-(3,4-dimethoxybenzyl)-6,7-dimethoxy-2-methyl-1,2,3,4-tetrahydroisoquinolinium] bisbenzenesulfonate;(1R,2R)-1-(3,4-dimethoxybenzyl)-2-(3-{[5-({3-[(2R,4R)-4-(3,4-dimethoxybenzyl)-6,7-dimethoxy-2-methyl-3,4-dihydroisoquinolinium-2(1H)-yl]propanoyl}oxy)pentyl]oxy}-3-oxopropyl)-6,7-dimethoxy-2-methyl-1,2,3,4-tetrahydroisoquinolinium bisbenzenesulfonate;Cisatracurium Besilete;Cis-Atracurium besilate;

• CAS NO :

  96946-42-8

• EC NO :

• Molecular Formula :

  C₆₅H₈₂N₂O₁₈S₂

• Molecular Weight :

  1243.47918

• Main Specifications :

• InChI :

  InChI=1/C53H72N2O12.2C6H6O3S/c1-54(34-39(26-36-14-16-44(58-3)46(28-36)60-5)41-32-50(64-9)49(63-8)31-40(41)35-54)21-19-52(56)66-24-12-11-13-25-67-53(57)20-23-55(2)22-18-38-30-48(62-7)51(65-10)33-42(38)43(55)27-37-15-17-45(59-4)47(29-37)61-6;2*7-10(8,9)6-4-2-1-3-5-6/h14-17,28-33,39,43H,11-13,18-27,34-35H2,1-10H3;2*1-5H,(H,7,8,9)/q+2;;/p-2/t39-,43+,54+,55+;;/m0../s1

• Molecular Structure :